Carregant...

Amniotic Fluid Stem Cells Inhibit the Progression of Bleomycin-Induced Pulmonary Fibrosis via CCL2 Modulation in Bronchoalveolar Lavage

The potential for amniotic fluid stem cell (AFSC) treatment to inhibit the progression of fibrotic lung injury has not been described. We have previously demonstrated that AFSC can attenuate both acute and chronic-fibrotic kidney injury through modification of the cytokine environment. Fibrotic lung...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Garcia, Orquidea, Carraro, Gianni, Turcatel, Gianluca, Hall, Marisa, Sedrakyan, Sargis, Roche, Tyler, Buckley, Sue, Driscoll, Barbara, Perin, Laura, Warburton, David
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742516/
https://ncbi.nlm.nih.gov/pubmed/23967234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0071679
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!